Literature DB >> 11665862

AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation.

C Culmsee1, J Monnig, B E Kemp, M P Mattson.   

Abstract

Adenosine monophosphate-activated protein kinase (AMPK) is a member of metabolite-sensing kinase family that plays important roles in responses of muscle cells to metabolic stress. AMPK is a heterotrimer of a catalytic alpha subunit (alpha1 or alpha2), and beta (beta1 or beta2) and gamma (gamma1 or gamma2) subunits. Because the brain has a high metabolic rate and is sensitive to changes in the supply of glucose and oxygen, we investigated the expression of AMPK in rat embryonic and adult brain and its role in modifying neuronal survival under conditions of cellular stress. We report that catalytic (alpha1 and alpha2) and noncatalytic (beta2 and gamma1) subunits of AMPK are present at high levels in embryonic hippocampal neurons in vivo and in cell culture. In the adult rat brain, the catalytic subunits alpha1 and alpha2 are present in neurons throughout the brain. The AMPK-activating agent AICAR protected hippocampal neurons against death induced by glucose deprivation, chemical hypoxia, and exposure to glutamate and amyloid beta-peptide. Suppression of levels of the AMPK alpha1 and alpha2 subunits using antisense technology resulted in enhanced neuronal death following glucose deprivation, and abolished the neuroprotective effect of AICAR. These findings suggest that AMPK can protect neurons against metabolic and excitotoxic insults relevant to the pathogenesis of several different neurodegenerative conditions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11665862     DOI: 10.1385/JMN:17:1:45

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   2.866


  59 in total

1.  NGF and bFGF protect rat hippocampal and human cortical neurons against hypoglycemic damage by stabilizing calcium homeostasis.

Authors:  B Cheng; M P Mattson
Journal:  Neuron       Date:  1991-12       Impact factor: 17.173

2.  Characterization of 5'AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia.

Authors:  N Kudo; J G Gillespie; L Kung; L A Witters; R Schulz; A S Clanachan; G D Lopaschuk
Journal:  Biochim Biophys Acta       Date:  1996-05-31

3.  Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase.

Authors:  S A Hawley; M Davison; A Woods; S P Davies; R K Beri; D Carling; D G Hardie
Journal:  J Biol Chem       Date:  1996-11-01       Impact factor: 5.157

4.  Phosphorylation of bovine hormone-sensitive lipase by the AMP-activated protein kinase. A possible antilipolytic mechanism.

Authors:  A J Garton; D G Campbell; D Carling; D G Hardie; R J Colbran; S J Yeaman
Journal:  Eur J Biochem       Date:  1989-01-15

5.  Catalytic subunits of the porcine and rat 5'-AMP-activated protein kinase are members of the SNF1 protein kinase family.

Authors:  G Gao; J Widmer; D Stapleton; T Teh; T Cox; B E Kemp; L A Witters
Journal:  Biochim Biophys Acta       Date:  1995-04-06

6.  Acadesine and myocardial protection. Studies of time of administration and dose-response relations in the rat.

Authors:  M Galiñanes; K M Mullane; D Bullough; D J Hearse
Journal:  Circulation       Date:  1992-08       Impact factor: 29.690

7.  Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death.

Authors:  R J Mark; K Hensley; D A Butterfield; M P Mattson
Journal:  J Neurosci       Date:  1995-09       Impact factor: 6.167

8.  Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase.

Authors:  M Endres; U Laufs; Z Huang; T Nakamura; P Huang; M A Moskowitz; J K Liao
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

9.  Mammalian AMP-activated protein kinase shares structural and functional homology with the catalytic domain of yeast Snf1 protein kinase.

Authors:  K I Mitchelhill; D Stapleton; G Gao; C House; B Michell; F Katsis; L A Witters; B E Kemp
Journal:  J Biol Chem       Date:  1994-01-28       Impact factor: 5.157

10.  5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?

Authors:  J M Corton; J G Gillespie; S A Hawley; D G Hardie
Journal:  Eur J Biochem       Date:  1995-04-15
View more
  135 in total

1.  Propolis ameliorates tumor nerosis factor-α, nitric oxide levels, caspase-3 and nitric oxide synthase activities in kainic acid mediated excitotoxicity in rat brain.

Authors:  Mummedy Swamy; Dian Suhaili; K N S Sirajudeen; Zulkarnain Mustapha; Chandran Govindasamy
Journal:  Afr J Tradit Complement Altern Med       Date:  2014-08-23

2.  AMP-activated protein kinase (AMPK) activating agents cause dephosphorylation of Akt and glycogen synthase kinase-3.

Authors:  Taj D King; Ling Song; Richard S Jope
Journal:  Biochem Pharmacol       Date:  2006-03-10       Impact factor: 5.858

3.  Activation of AMP-activated protein kinase in cerebella of Atm-/- mice is attributable to accumulation of reactive oxygen species.

Authors:  Xianghong Kuang; Mingshan Yan; Joanne M Ajmo; Virginia L Scofield; George Stoica; Paul K Y Wong
Journal:  Biochem Biophys Res Commun       Date:  2012-01-10       Impact factor: 3.575

4.  Lithium prevents long-term neural and behavioral pathology induced by early alcohol exposure.

Authors:  B Sadrian; S Subbanna; D A Wilson; B S Basavarajappa; M Saito
Journal:  Neuroscience       Date:  2012-01-08       Impact factor: 3.590

Review 5.  Energy dysfunction in Huntington's disease: insights from PGC-1α, AMPK, and CKB.

Authors:  Tz-Chuen Ju; Yow-Sien Lin; Yijuang Chern
Journal:  Cell Mol Life Sci       Date:  2012-05-25       Impact factor: 9.261

6.  Cadmium induction of reactive oxygen species activates the mTOR pathway, leading to neuronal cell death.

Authors:  Long Chen; Baoshan Xu; Lei Liu; Yan Luo; Hongyu Zhou; Wenxing Chen; Tao Shen; Xiuzhen Han; Christopher D Kontos; Shile Huang
Journal:  Free Radic Biol Med       Date:  2010-12-30       Impact factor: 7.376

7.  AMPK Inhibition Enhances the Neurotoxicity of Cu(II) in SH-SY5Y Cells.

Authors:  Ai-Ping Lan; Xian-Jia Xiong; Jun Chen; Xi Wang; Zhi-Fang Chai; Yi Hu
Journal:  Neurotox Res       Date:  2016-07-19       Impact factor: 3.911

8.  Neuroprotective Effect of Osthole on Neuron Synapses in an Alzheimer's Disease Cell Model via Upregulation of MicroRNA-9.

Authors:  Shaoheng Li; Yuhui Yan; Yanan Jiao; Zhong Gao; Yang Xia; Liang Kong; Yingjia Yao; Zhenyu Tao; Jie Song; Yaping Yan; Guangxian Zhang; Jingxian Yang
Journal:  J Mol Neurosci       Date:  2016-07-09       Impact factor: 3.444

Review 9.  Effects of AMP-activated protein kinase in cerebral ischemia.

Authors:  Jun Li; Louise D McCullough
Journal:  J Cereb Blood Flow Metab       Date:  2009-12-16       Impact factor: 6.200

10.  The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of Aβ oligomers through Tau phosphorylation.

Authors:  Georges Mairet-Coello; Julien Courchet; Simon Pieraut; Virginie Courchet; Anton Maximov; Franck Polleux
Journal:  Neuron       Date:  2013-04-10       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.